Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
NOVO HOLDINGS A/S (CIK 1388325) reported $1.72B across 25 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: EWTX ($217.4M, 12.62%), ASML ($188.9M, 10.97%), COAG ($153.6M, 8.92%), BN ($149.5M, 8.68%), MPLT ($132.1M, 7.67%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | EWTX | EDGEWISE THERAPEUTICS INC | $217.4M | 12.62% | 5.3M | Hold |
| 2 | ASML | ASML HOLDING N V | $188.9M | 10.97% | 94,946 | Hold |
| 3 | COAG | HEMAB THERAPEUTICS HLDGS INC | $153.6M | 8.92% | 4.2M | New |
| 4 | BN | BROOKFIELD CORP | $149.5M | 8.68% | 3.5M | Hold |
| 5 | MPLT | MAPLIGHT THERAPEUTICS INC | $132.1M | 7.67% | 3.7M | Hold |
| 6 | MIRM | MIRUM PHARMACEUTICALS INC | $131.7M | 7.65% | 1.1M | Trimmed |
| 7 | AVLN | AVALYN PHARMACEUTICALS INC | $127.8M | 7.42% | 3.9M | New |
| 8 | CRM | SALESFORCE INC | $61.6M | 3.58% | 393,187 | Hold |
| 9 | AVBP | ARRIVENT BIOPHARMA INC | $52.1M | 3.03% | 1.5M | Trimmed |
| 10 | ELVN | ENLIVEN THERAPEUTICS INC | $50.8M | 2.95% | 1.0M | Trimmed |
| 11 | CRNX | CRINETICS PHARMACEUTICALS IN | $49.4M | 2.87% | 1.3M | Trimmed |
| 12 | PHVS | PHARVARIS N V | $48.4M | 2.81% | 1.4M | Trimmed |
| 13 | FND | FLOOR & DECOR HLDGS INC | $47.3M | 2.75% | 797,000 | New |
| 14 | PCVX | VAXCYTE INC | $46.5M | 2.70% | 800,000 | Trimmed |
| 15 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $43.2M | 2.51% | 3.2M | Trimmed |
| 16 | VRDN | VIRIDIAN THERAPEUTICS INC | $39.2M | 2.28% | 2.1M | Added |
| 17 | CLDX | CELLDEX THERAPEUTICS INC NEW | $38.1M | 2.21% | 1.0M | Trimmed |
| 18 | ALMS | ALUMIS INC | $31.0M | 1.80% | 1.1M | New |
| 19 | XENE | XENON PHARMACEUTICALS INC | $29.3M | 1.70% | 485,438 | Hold |
| 20 | BABA | ALIBABA GROUP HLDG LTD | $24.7M | 1.43% | 257,327 | Hold |
| 21 | DYN | DYNE THERAPEUTICS INC | $21.3M | 1.24% | 960,394 | New |
| 22 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $17.1M | 1.00% | 2.2M | Added |
| 23 | INSM | INSMED INC | $12.9M | 0.75% | 120,723 | New |
| 24 | MQ | MARQETA INC | $7.2M | 0.42% | 441,558 | Hold |
| 25 | LNZA | LANZATECH GLOBAL INC | $1.1M | 0.06% | 158,148 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30